Rose Merc Limited Allots 22,222 Equity Shares Upon Conversion of Warrants on May 7, 2026

Rose Merc Limited's Allotment Committee, constituted by the Board of Directors, convened on Thursday, May 7, 2026, at the company's registered office in Sion West, Mumbai, and approved the allotment of 22,222 fully paid-up equity shares of face value Rs. 10/- each. The allotment was effected upon conversion of equity warrants issued on a preferential basis, in compliance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The committee meeting commenced at 03.00 p.m. and concluded at 03.30 p.m.

Allotment Details

The 22,222 equity shares were allotted to a single non-promoter allottee at an issue price of Rs. 90/- per share, which includes a premium of Rs. 80/- over the face value of Rs. 10/-. The following table summarises the allotment:

Parameter: Details Type of Securities: Equity Shares Type of Issuance: Conversion of Equity Warrants (Preferential Basis) Number of Shares Allotted: 22,222 fully paid-up equity shares Face Value: Rs. 10/- per share Issue Price: Rs. 90/- per share (including premium of Rs. 80/-) Allottee: Vikas Pandurang Kolarkar Category: Non-Promoter

Allottee Breakdown

The entire allotment of 22,222 equity shares was made to one allottee upon conversion of an equivalent number of warrants, as detailed below:

Sr. No: Name of Allottee: Category: Warrants Converted: Equity Shares Allotted: 1 Vikas Pandurang Kolarkar Non-Promoter 22,222 22,222 Total 22,222 22,222

Post-Allotment Capital Structure

Following the allotment, the paid-up share capital of Rose Merc Limited has been revised. The table below presents the bifurcation of the post-allotment capital structure:

Component: Details Existing Share Capital: 61,94,185 equity shares of Rs. 10/- each aggregating to Rs. 6,19,41,850/- Equity Shares Added (Warrant Conversion): 22,222 equity shares of Rs. 10/- each aggregating to Rs. 2,22,220/- Post-Allotment Paid-Up Capital: Rs. 6,21,64,070 comprising 62,16,407 equity shares of Rs. 10/- each

The disclosure has been made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with SEBI Circular No. CIR/CFD/CMD/4/2015 dated September 09, 2015. There are no cancellations or terminations associated with this issuance.

Rose Merc Limited filed a revised outcome of its Allotment Committee meeting held on May 06, 2026, correcting a typographical error in the earlier disclosure pertaining to the number of warrant holders whose warrants were converted into equity shares. The revision was submitted to BSE Limited on May 07, 2026, pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. Except for the correction of the warrant holder count, all other details from the earlier intimation remain unchanged.

Revised Allotment Details

The Allotment Committee, constituted by the Board of Directors, approved the allotment of 50,500 fully paid-up equity shares of face value Rs.10 each, upon conversion of warrants held by 2 warrant holders. The shares were allotted at Rs.90 per share, inclusive of a premium of Rs.80 per share. Both allottees are categorised as non-promoters, with Salil Divakar Deshpande receiving 50,000 shares and Bharat Ramdas Karnik receiving 500 shares.

Sr. No.: Name of Allottee Category No. of Warrants Converted No. of Equity Shares Allotted 1 Bharat Ramdas Karnik Non-Promoter 500 500 2 Salil Divakar Deshpande Non-Promoter 50,000 50,000 Total 50,500 50,500

Capital Structure Impact

Following the allotment of 50,500 equity shares, the company's post-allotment paid-up capital stands at Rs.6,19,41,850, comprising 61,94,185 equity shares of Rs.10 each. Prior to this allotment, the existing share capital was 61,43,685 equity shares aggregating to Rs.6,14,36,850. The conversion of warrants added 50,500 equity shares amounting to Rs.5,05,000 to the equity share capital.

The committee meeting was held at the company's registered office at 15/B/4, New Sion CHS, Opp. SIES College, Behind D Mart, Sion West, Mumbai – 400022, Maharashtra, commencing at 5:45 p.m. and concluding at 6:00 p.m. The disclosure was signed by Vaishali Parkar Kumar, Managing Director (DIN: 09159108), and submitted to BSE Limited in accordance with SEBI Circular No. CIR/CFD/CMD/4/2015 dated September 09, 2015.

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.

As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation.

We plan to change that - a technology-led and artificial intelligence enabled platform built for super traders and long term investors.

Disclaimer:

The data and information provided on this website is for general informational and research purposes only. While we strive to ensure that the content is accurate, up-to-date, and reliable, this platform utilizes artificial intelligence (AI) tools to generate, curate, and summarize information. As such, the content may occasionally contain errors, omissions, or outdated information. All users are therefore advised to cross verify the source of the data and information.

This website does not constitute professional, legal, financial, medical, or any other form of licensed advice. Users are encouraged to independently verify any information before relying on it, especially for decisions that may have legal, financial, or personal consequences.

The views, analyses, and summaries presented on this platform may be generated or assisted by AI and do not necessarily reflect the opinions of the website owners, operators, editors, or affiliates.

We make no warranties or representations, express or implied, regarding the completeness, accuracy, reliability, suitability, or availability of the information contained on this website. Any reliance you place on such information is strictly at your own risk.

This website may include links to third-party sources or content. We do not control or endorse the nature, accuracy, or availability of those external sites and are not responsible for any content or damages arising from their use.

By using this website, you acknowledge and agree that the use of AI-generated content involves inherent limitations, uncertainties and inaccuracies, and you accept full responsibility for how you interpret and use the information provided.

We reserve the right to modify, update, or remove content and this disclaimer at any time without prior notice.